GlassScriptPhysician profile
Allison R Bootin
NPI 1689296402
$17,817.80
in general payments reported to CMS, 2019-2025
31 companies · $2,837 in 2025
The $2,837 reported for 2025 was more than what 96% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $11.61 · 2021: $2,195 · 2022: $3,967 · 2023: $4,114 · 2024: $4,694 · 2025: $2,837.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Consulting Fee: $810 · Education: $332 · Travel and Lodging: $27.07.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,474.28 |
| Consulting Fee | $810.00 |
| Education | $332.37 |
| Travel and Lodging | $27.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $5,934.66 | 2021-2025 | |
| Dermavant Sciences, INC. | $1,752.17 | 2023-2024 | Vtama |
| Allergan, INC. | $1,261.15 | 2021-2022 | |
| Arcutis Biotherapeutics, INC. | $1,157.48 | 2023-2025 | Zoryve |
| Regeneron Healthcare Solutions, INC. | $969.82 | 2021-2025 | Dupixent |
| E.R. Squibb & Sons, L.L.C. | $780.91 | 2022-2025 | Sotyktu |
| Sun Pharmaceutical Industries INC. | $710.34 | 2021-2025 | |
| Genzyme Corporation | $658.13 | 2021-2025 | |
| Lilly USA, LLC | $657.48 | 2021-2025 | Taltz, Ebglyss, Olumiant |
| Janssen Biotech, INC. | $559.32 | 2021-2025 | Tremfya |
| Novartis Pharmaceuticals Corporation | $444.14 | 2021-2025 | |
| Ucb, INC. | $340.17 | 2021-2025 | Bimzelx, Cimzia |
| Almirall LLC | $283.76 | 2021-2024 | Klisyri |
| Incyte Corporation | $281.23 | 2021-2025 | Opzelura |
| Galderma Laboratories, L.P. | $279.36 | 2021-2025 | Aklief |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Journey Medical Corporation | $261.66 | 2022-2023 | |
| Pfizer INC. | $261.40 | 2021-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $238.74 | 2021-2025 | Siliq, Arazlo, Jublia |
| Amgen INC. | $210.45 | 2021-2023 | Otezla |
| Vyne Pharmaceuticals INC. | $187.03 | 2021 | |
| Smith+Nephew, INC. | $120.14 | 2022 | |
| Leo Pharma INC. | $98.60 | 2022-2025 | Anzupgo |
| Organon LLC | $92.96 | 2025 | Vtama |
| Fresenius Kabi USA, LLC | $68.71 | 2023 | Idacio |
| Revance Therapeutics, INC. | $48.65 | 2025 | Daxxify |
| Mayne Pharma Commercial LLC | $44.25 | 2020-2022 | |
| Helsinn Therapeutics (U.S.), INC. | $35.94 | 2021 | |
| Biofrontera INC. | $25.78 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.36 | 2022 | |
| Sandoz INC. | $19.16 | 2023 | |
| Solta Medical, A Division of Bausch Health US, LLC | $11.85 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Bootin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.